1. Short title This Act may be cited as the Accelerating Biomedical Innovation Act . 2. Center for biomedical innovation and development program Title III of the Public Health Service Act ( 42 U.S.C. 241 et seq. ) is amended by inserting after section 319L–1 the following: 319L–2. Center for biomedical innovation and development program (a) Establishment of consortium Not later than 1 year after the date of enactment of this section, the Secretary shall establish a consortium of not fewer than 3 institutions of higher education (as defined in section 101 of the Higher Education Act), to accelerate innovation and development of advanced medical countermeasure products, including biological products and devices, selected by the Biomedical Advanced Research and Development Agency (referred to in this section as BARDA ). Such consortium shall be known as the Center for Biomedical Innovation and Development (referred to in this section as the Center ). (b) Selection of participating institutions In selecting institutions of higher education to participate in the Center under subsection (a), the Secretary shall— (1) select eligible institutions that have— (A) expertise and capabilities in current good manufacturing practices, as defined in part 117 of title 21 Code of Federal Regulations (or successor regulations); (B) experience in technology innovation, including advanced manufacturing technologies, that may assist in countermeasure and advanced research and development; (C) facilities with flexible and adaptable advanced process development capabilities; and (D) other relevant qualifications, as determined by the Secretary; (2) select at least one institution with the capability to handle secure and classified information, as appropriate